Quote | Alaunos Therapeutics Inc. (NASDAQ:TCRT)
Last: | $0.5001 |
---|---|
Change Percent: | 8.33% |
Open: | $0.55 |
Close: | $0.5001 |
High: | $0.5696 |
Low: | $0.5 |
Volume: | 2,148,811 |
Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Alaunos Therapeutics Inc. (NASDAQ:TCRT)
2023-05-26 15:36:17 ET Alaunos Therapeutics ( NASDAQ: TCRT ) fell ~17% on Friday as investors reacted to data from a Phase 1/2 trial for its T-cell receptor (TCR) cell therapy candidate in patients with solid tumors harboring KRAS or TP53 genetic mutations. As of Feb. 2023, ...
TCR-T cell therapy shows first-in-human response for non-viral TCR-T therapy; effectively targets high frequency TP53 and KRAS driver mutations across multiple solid tumor indications Treatment was well tolerated with a manageable safety profile and persistence of TCR-T cells in perip...
Message Board Posts | Alaunos Therapeutics Inc. (NASDAQ:TCRT)
Subject | By | Source | When |
---|---|---|---|
They filed an 8-K: | vpagano | investorshub | 10/07/2022 3:57:55 AM |
I can not find any article or info | eddyimano | investorshub | 10/06/2022 4:29:34 PM |
3$+ this week | ollik78 | investorshub | 09/26/2022 8:48:05 PM |
Lol... good for you my friend. Hope you | PennyPusher786 | investorshub | 09/26/2022 8:41:23 PM |
Watch on Sept 30. Boom. To Uranus and beyond | howardriggin | investorshub | 09/26/2022 7:28:32 PM |